NCT02608606View on ClinicalTrials.gov

Determining Equivalence Dose for Oral Versus Sublingual Administration of Tacrolimus in Hepatic Receptors

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions

Evidence of Liver TransplantationEffects of Immunosuppressant Therapy

Interventions

DRUG

Tacrolimus

compared oral administration versus sublingual administration of tacrolimus.

Trial Locations (1)

8330024

Pontificia Universidad Catolica de Chile, Santiago

All Listed Sponsors

lead

Pontificia Universidad Catolica de Chile

OTHER

NCT02608606 - Determining Equivalence Dose for Oral Versus Sublingual Administration of Tacrolimus in Hepatic Receptors | Biotech Hunter | Biotech Hunter